News Daily News FDA Approves Baroreflex Activation Therapy Device for Advanced Heart Failure Todd Neale August 19, 2019
News Daily News FDA Advisors Give Blessing to Implantable Pulse Generator in Certain Heart Failure Patients Yael L. Maxwell December 05, 2018
News Daily News Andexanet Alfa, First Reversal Agent for Factor Xa Inhibitors, Finally Gains FDA Approval Todd Neale May 04, 2018
News Daily News Year in Review: Physicians Pick the Biggest News of 2017, in Interventional Cardiology and Beyond Shelley Wood December 26, 2017
News Daily News FDA Declines to Approve Portola’s Reversal Agent for Factor Xa Inhibitors Michael O'Riordan August 18, 2016